¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"ü"¿¡ ´ëÇÑ ´ëÇÑ»ýÈÇкÐÀÚ»ý¹°ÇÐȸ ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑ»ýÈÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
antibody
Ç×ü(ù÷ô÷)
antibody binding fraction
Ç×ü°áÇÕºÐȹ (ù÷ô÷Ì¿ùêÝÂüò)
antibody combining site
Ç×ü°áÂø(ù÷ô÷Ì¿ó·)ÀÚ¸®
antibody dependent cellular cytotoxicity
Ç×üÀÇÁ¸ÀÚ¸® ¼¼Æ÷¼º¼¼Æ÷µ¶¼º(ù÷ô÷ëîðíá¬øààõá¬øàÔ¸àõ)
antibody diversity
Ç×ü ´Ù¾ç¼º(ù÷ô÷ÒýåÆàõ)
antibody fixation
Ç×ü °íÁ¤(ù÷ô÷ͳïÒ)
antibody formation
Ç×ü Çü¼º(ù÷ô÷û¡à÷)
antibody heterogeneity
Ç×ü ºÒ±ÕÀϼº(ù÷ô÷ÝÕгìéàõ)
antibody mediated hypersensitivity
Ç×ü ¸Å°³ °ú¹ÎÁõ(ù÷ô÷ØÚ˿ΦÚÂñø)
antibody response
Ç×ü ´ëÀÀ(ù÷ô÷Óßëë)
antibody specificity
Ç×ü ƯÀ̼º(ù÷ô÷÷åì¶àõ)
antibody titer
Ç×ü¿ª°¡(ù÷ô÷æ³Ê¤)
antibody valence
Ç×ü°¡(ù÷ô÷ʤ)
antibody-excess zone
Ç×ü°úÀ×±¸¿ª(ù÷ô÷Φí¥Ï¡æ´)
anticomplement fluorescent antibody technique
Ç׺¸Ã¼ Çü±¤Ç×ü¼ú(ù÷ÜÍô÷û«ÎÃù÷ô÷âú)
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑ»ýÈÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
3
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½